UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 25, 2014
CAS MEDICAL SYSTEMS, INC.
(Exact name of Registrant as specified in its charter)
|
Delaware
(State or other jurisdiction
of incorporation)
|
0-13839
(Commission
File Number)
|
06-1123096
(I.R.S. Employer
Identification No.)
|
|
|
44 East Industrial Road, Branford, Connecticut 06405
(Address of principal executive offices, including zip code)
(203) 488-6056
(Registrant's telephone number, including area code)
|
|||
|
|
|||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
Stockholder Approval of 2011 Equity Incentive Plan, as amended
On April 25, 2014, the Compensation Committee of the Board of Directors of CAS Medical Systems, Inc. (the “Company”) approved an amendment to the CAS Medical Systems, Inc. 2011 Equity Incentive Plan (the "Incentive Plan"), subject to stockholder approval, to increase the number of shares of Company common stock available for grant under the Incentive Plan from a maximum of 2,000,000 shares to a maximum of 3,000,000 shares. The existing sublimit of a maximum of 500,000 shares available for delivery with respect to awards of restricted stock and restricted stock units remained unchanged. On June 25, 2014, at the Company’s annual meeting of stockholders, the Incentive Plan, as amended, was approved by the Company’s stockholders.
The foregoing description of the Incentive Plan does not purport to be complete and is qualified in its entirety by reference to the Incentive Plan, as amended, a copy of which is incorporated by reference herein and was filed with the Securities and Exchange Commission as an exhibit to the Company's proxy statement for the 2014 annual meeting.
|
Item 5.07
|
Submission of Matters to a Vote of Security Holders.
|
At the annual meeting of stockholders of the Company held on June 25, 2014, four proposals were voted upon and approved by the Company’s stockholders. A brief description of each proposal voted upon at the annual meeting and the number of votes cast for, against and withheld, as well as the number of abstentions and broker non-votes, where applicable, are set forth below.
A total of 24,735,778 votes were eligible to be cast at the annual meeting, consisting of (i) 19,416,629 shares of Company common stock and (ii) 95,500 shares of the Company’s Series A Convertible Preferred Stock and 54,500 shares of the Company’s Series A Exchangeable Preferred Stock (which is substantially identical to the Series A Convertible Preferred Stock) containing voting rights equivalent to a total of 5,319,149 shares of common stock.
(1) Election of members of the Board of Directors, each for a term of one year
|
Nominee
|
For
|
Withheld
|
Broker
Non-Votes
|
|
|
Lawrence S. Burstein
|
13,042,628
|
235,200
|
8,780,586
|
|
|
Thomas M. Patton
|
13,263,552
|
14,276
|
8,780,586
|
|
|
Gregory Rainey
|
13,045,658
|
232,170
|
8,780,586
|
|
|
James E. Thomas
|
13,035,258
|
242,570
|
8,780,586
|
|
|
Kathleen A. Tune
|
13,249,922
|
27,906
|
8,780,586
|
|
|
Kenneth R. Weisshaar
|
13,263,552
|
14,276
|
8,780,586
|
- 2 -
(2) Approval of the 2011 Equity Incentive Plan, as amended
|
For
|
Against
|
Abstain
|
Broker
Non-Votes
|
|
12,503,045
|
352,896
|
421,887
|
8,780,586
|
(3) Advisory approval of the compensation of the Company’s named executive officers
|
For
|
Against
|
Abstain
|
Broker
Non-Votes
|
|
12,854,295
|
74,346
|
349,187
|
8,780,586
|
(4) Ratification of the appointment of CohnReznick LLP as auditor for the Company for the fiscal year ending December 31, 2014
|
For
|
Against
|
Abstain
|
|
|
22,005,982
|
44,472
|
7,960
|
|
|
Item 9.01
|
Financial Statements and Exhibits
|
|
(d)
|
The following exhibit is filed as part of this report:
|
|
10.1
|
CAS Medical Systems, Inc. 2011 Equity Incentive Plan, as amended (incorporated by reference to the Company’s proxy statement filed on April 29, 2014)
|
- 3 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CAS MEDICAL SYSTEMS, INC. | |||
|
Date: June 27, 2014
|
By: | /s/ Jeffery A. Baird | |
|
Jeffery A. Baird
|
|||
|
Chief Financial Officer
|
|||
- 4 -